These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29423783)

  • 1. Peyronie's disease and Dupuytren's contracture secondary to topical timolol.
    Oliphant H; Gouws P
    Int Ophthalmol; 2019 Mar; 39(3):683-685. PubMed ID: 29423783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peyronie's disease following long-term use of topical timolol.
    Ross JJ; Rahman I; Walters RF
    Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
    [No Abstract]   [Full Text] [Related]  

  • 3. Patients with Dupuytren's Contracture, Ledderhose Disease, and Peyronie's Disease are at higher risk of arthrofibrosis following total knee arthroplasty.
    Wang CX; Flick TR; Patel AH; Sanchez F; Sherman WF
    Knee; 2021 Mar; 29():190-200. PubMed ID: 33640618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peyronie's disease associated with Dupuytren's contracture.
    WALLER JI; DREESE WC
    J Urol; 1952 Sep; 68(3):623-5. PubMed ID: 12991360
    [No Abstract]   [Full Text] [Related]  

  • 5. Focused extracorporeal shockwave therapy in Dupuytren's disease--a hypothesis.
    Knobloch K; Kuehn M; Vogt PM
    Med Hypotheses; 2011 May; 76(5):635-7. PubMed ID: 21277691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A COLLAGEN TRIAD: LA PEYRONIE'S DISEASE, DUPUYTREN'S DISEASE AND FIBROSIS OF THE AURICULAR CARTILAGE].
    GALLIZIA F
    J Urol Nephrol (Paris); 1964 Jun; 70():424-7. PubMed ID: 14171347
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between Peyronie's and Dupuytren's disease.
    Nugteren HM; Nijman JM; de Jong IJ; van Driel MF
    Int J Impot Res; 2011; 23(4):142-5. PubMed ID: 21633367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocopherols in treatment of primary fibrositis; including Dupuytren's contracture, periarthritis of the shoulders, and Peyronie's disease.
    STEINBERG CL
    AMA Arch Surg; 1951 Dec; 63(6):824-33. PubMed ID: 14868250
    [No Abstract]   [Full Text] [Related]  

  • 10. [Association of vascular allergids with Peyronie's and Dupuytren's disease. Favorable therapeutic effects of delta-butazolidine].
    TEODORESCO S; BADANOIU A
    Bull Soc Fr Dermatol Syphiligr; 1962; 69():295-300. PubMed ID: 13980590
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of an immunodepressive treatment in La Peyronie's disease, Dupuytren's disease and certain sclerodermas].
    Sturm M; Lebeuf M
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(5):523-5. PubMed ID: 5152896
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Sampaio FJ
    Int Braz J Urol; 2004; 30(4):349-50. PubMed ID: 15679983
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Peyronie's and Dupuytren's diseases in an individual after single episodes of trauma: a case report and review of the literature.
    Connelly TJ
    J Am Acad Dermatol; 1999 Jul; 41(1):106-8. PubMed ID: 10411420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
    Rom M; Schwartz B; Bealka N
    J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.
    Nyberg LM; Bias WB; Hochberg MC; Walsh PC
    J Urol; 1982 Jul; 128(1):48-51. PubMed ID: 6980996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of collagen in Peyronie's disease.
    Somers KD; Sismour EN; Wright GL; Devine CJ; Gilbert DA; Horton CE
    J Urol; 1989 Mar; 141(3):629-31. PubMed ID: 2918606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peyronie's disease and peripheral neuropathies].
    Diagne M; Gueye SM; Ba M; Konan PG; Diop AG; Ndiaye MM; Ndiaye IP; Mensah A
    Dakar Med; 1998; 43(2):234-7. PubMed ID: 10797972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peyronie's disease: a newly recognized autosomal-dominant trait.
    Bias WB; Nyberg LM; Hochberg MC; Walsh PC
    Am J Med Genet; 1982 Jun; 12(2):227-35. PubMed ID: 6213155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.